5AM Opportunities I, L.P.
10% Owner

5AM Opportunities I, L.P. insider trades: Entrada Therapeutics (TRDA) stock buys and sales

10% Owner, Entrada Therapeutics Last trade Aug 7, 2026 43 Form 4 filings
$3.0M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
64
Open-market trades
since 2019
12
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where 5AM Opportunities I, L.P. reports to the SEC

and 6 more companies

Open-market buys and sales

64 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 7, 2026TRDA↓ Sell$432K
Jul 31, 2026TRDA↓ Sell$807K
Nov 14, 2025TRDA↓ Sell$1.8M
Jul 9, 2025TRDA↓ Sell$151K
Jul 9, 2025TRDA↓ Sell$52K
Jul 1, 2025TRDA↓ Sell$644K
Jul 1, 2025TRDA↓ Sell$223K
Feb 14, 2024ELVN↓ Sell$10.3M
Feb 14, 2024ELVN↓ Sell$2.0M
Jan 31, 2024ELVN↓ Sell$6.3M
Jan 31, 2024ELVN↓ Sell$1.2M
Sep 26, 2023ELVN↓ Sell$2.5M
Sep 26, 2023ELVN↓ Sell$491K
Aug 24, 2023ELVN↓ Sell$5.9M
Aug 24, 2023ELVN↓ Sell$1.2M
Apr 10, 2023PEAR↓ Sell$1.5M
Apr 10, 2023PEAR↓ Sell$381K
Apr 10, 2023PEAR↓ Sell$64K
Nov 15, 2022PEAR↓ Sell$277K
Nov 15, 2022PEAR↓ Sell$12K
Nov 2, 2022PEAR↓ Sell$144K
Nov 2, 2022PEAR↓ Sell$6K
Oct 10, 2022SCPH↓ Sell$2.0M
Oct 10, 2022SCPH↓ Sell$385K
Oct 10, 2022SCPH↓ Sell$84K
Sep 16, 2022PEAR↓ Sell$1.0M
Sep 16, 2022PEAR↓ Sell$42K
Sep 8, 2022PEAR↓ Sell$1.5M
Sep 8, 2022PEAR↓ Sell$63K
Sep 7, 2022SCPH↓ Sell$894K
Sep 7, 2022SCPH↓ Sell$165K
Sep 7, 2022SCPH↓ Sell$37K
Aug 18, 2022PEAR↓ Sell$634K
Aug 18, 2022PEAR↓ Sell$26K
Aug 15, 2022CINC↑ Buy$14.6M
Aug 15, 2022CINC↑ Buy$3.4M
Jun 3, 2022RLYB↓ Sell$1.2M
Jun 3, 2022RLYB↓ Sell$629K
May 23, 2022RLYB↓ Sell$864K
May 23, 2022RLYB↓ Sell$436K
Apr 11, 2022SCPH↓ Sell$1.1M
Apr 11, 2022SCPH↓ Sell$204K
Apr 11, 2022SCPH↓ Sell$46K
Feb 8, 2022RLYB↓ Sell$2.7M
Jan 11, 2022CINC↑ Buy$5.0M
Jan 11, 2022CINC↑ Buy$2.5M
Nov 16, 2021VOR↓ Sell$5.1M
Nov 2, 2021TRDA↑ Buy$5.0M
Nov 1, 2021CABA↓ Sell$3.8M
Sep 7, 2021CABA↓ Sell$6.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TRDA insiders

Open-market trades in the last 12 months

About 5AM Opportunities I, L.P.'s insider trades

5AM Opportunities I, L.P. is a 10% owner of Entrada Therapeutics (TRDA). Since Oct 7, 2019, it has reported 11 open-market purchases worth $72.1M and 53 sales worth $119.3M on SEC Form 4. In the last 12 months: 3 sales ($3.0M).

Its filings also include conversions (7 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.